Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -247,115 | -120,613 | -413,840 | -307,391 | -196,269 |
| Depreciation Amortization | 212 | 107 | 377 | 268 | 169 |
| Accounts receivable | 104 | 129 | 3,232 | 3,147 | 3,344 |
| Accounts payable and accrued liabilities | -10,466 | -9,401 | 10,939 | 12,988 | 13,248 |
| Other Working Capital | -4,939 | -15,439 | -12,031 | 3,975 | 5,018 |
| Other Operating Activity | 42,278 | 27,806 | 35,449 | 21,776 | 9,644 |
| Operating Cash Flow | $-219,926 | $-117,411 | $-375,874 | $-265,237 | $-164,846 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -759 | -558 | -378 |
| Investing Cash Flow | $N/A | $N/A | $-759 | $-558 | $-378 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,513 | 2,918 | 454,811 | 3,880 | 1,416 |
| Other Financing Activity | 0 | 0 | -319 | 0 | 0 |
| Financing Cash Flow | $27,513 | $2,918 | $454,492 | $3,880 | $1,416 |
| Exchange Rate Effect | 312 | -566 | 747 | 1,235 | 1,384 |
| Beginning Cash Position | 713,971 | 713,971 | 635,365 | 635,365 | 635,365 |
| End Cash Position | 521,870 | 598,912 | 713,971 | 374,685 | 472,941 |
| Net Cash Flow | $-192,101 | $-115,059 | $78,606 | $-260,680 | $-162,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -219,926 | -117,411 | -375,874 | -265,237 | -164,846 |
| Capital Expenditure | N/A | N/A | -759 | -558 | -378 |
| Free Cash Flow | -219,926 | -117,411 | -376,633 | -265,795 | -165,224 |